Company Overview and News

 
Community Health Systems To Broadcast First Quarter 2018 Conference Call Live On The Internet

2018-04-17 globenewswire
FRANKLIN, Tenn., April 17, 2018 (GLOBE NEWSWIRE) -- Community Health Systems, Inc. (NYSE:CYH) today announced that it will provide an online Web simulcast and rebroadcast of its first quarter 2018 conference call.
Upvote Downvote

1
8 Best Cheap Stocks to Buy Now Under $10

2018-04-10 investorplace
The best cheap stocks to buy now are never sure things. There are many stocks under $10 right now that deserve to be there, and will only get cheaper.
Upvote Downvote

1
CYH / Community Health Systems, Inc. DEF 14A

2018-04-06 sec.gov
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A
Upvote Downvote

2
CYH / Community Health Systems, Inc. DEFA14A

2018-04-06 sec.gov
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATE
Upvote Downvote

 
CYH / Community Health Systems, Inc. 8-K (Current Report)

2018-04-04 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549
Upvote Downvote

 
Quorum Health: Disconnect Between Challenged Fundamentals And Lofty Valuation

2018-03-29 seekingalpha
It does not generate positive cash flow; unless QHC de-levers, cash flow will not occur as LIBOR-based variable rate debt becomes increasingly problematic.
Upvote Downvote

 
Quorum Health: Disconnect Between Challenged Fundamentals & Lofty Valuation

2018-03-29 seekingalpha
It does not generate positive cash flow; unless QHC de-levers, cash flow will not occur as LIBOR-based variable rate debt becomes increasingly problematic.
Upvote Downvote

 
The 7 Most Undervalued Stocks In Larry Robbins’ Portfolio

2018-03-28 investorplace
Larry Robbins is a hedge fund manager and CEO of Glenview Capital Management. He is also well known for his quarterly letters to investors.
Upvote Downvote

 
Implied Volatility Surging for Community Health (CYH) Stock Options

2018-03-27 zacks
Investors in Community Health Systems, Inc. (CYH - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 15, 2018 $10 Put had some of the highest implied volatility of all equity options today.
Upvote Downvote

 
Community Health Systems: Should Bondholders Be Wary?

2018-03-26 seekingalpha
Community Health Systems' (CYH) recent announcement that they were tapping Lazard to help manage their debt situation created some concern for equity and debt holders. Prices for the company’s unsecured 2019 maturities sank to 89 cents on the dollar. Combined with an 8% coupon, the bond’s yield to maturity is quickly approaching 16%. To determine bondholder risk, we need to examine the company’s financial results combined with 2018 guidance and asset sale expectations to see if the worry is overrated.
Upvote Downvote

 
CYH / Community Health Systems, Inc. FORM 8-K (Current Report)

2018-03-26 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549
Upvote Downvote

 
Why did Community Health Stock Sink More Than 50% in a Year?

2018-03-21 zacks
Community Health Systems, Inc. (CYH - Free Report) has been losing out on investors’ confidence due to the stock’s persistently poor performance in comparison to the industry as well as its peers. The company’s lower-than-expected volumes, payer rates, increased bad debt, a weak top line combined with higher operating expenses leading to a further drag in the margin have likely caused this underperformance.
Upvote Downvote

 
CYH / Community Health Systems, Inc. FORM 8-K (Current Report)

2018-03-20 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549
Upvote Downvote

 
Quorum Health's (QHC) CEO Tom Miller on Q4 2017 Results - Earnings Call Transcript

2018-03-16 seekingalpha
Good morning. My name is Heidi, and I will be your conference operator today. At this time, I would like to welcome everyone to the Quorum Health Fourth Quarter 2017 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. [Operator Instructions]. Thank you.
Upvote Downvote

 
CYH / Community Health Systems, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G (Passive Investment)

2018-03-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Community Health Systems, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 203668116 (CUSIP Number)
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 203668108